Early Detection and Intervention for the Prevention of Psychosis
Public ClinicalTrials.gov record NCT00531518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Early Detection and Intervention for the Prevention of Psychosis Project
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
EDIPP is a multisite trial of early identification and intervention to prevent the onset of psychosis in adolescents and young adults, carried out at six sites across the United States. The hypothesis is that very early identification and intervention will be effective in delaying or preventing onset of psychosis and improving social and occupational functioning.
Study identification
- NCT ID
- NCT00531518
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 292 participants
Conditions and interventions
Interventions
- aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine Drug
- Psychoeducational multifamily group treatment Behavioral
- Supported employment and education Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 12 Years to 25 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Aug 15, 2016
2007 – 2013
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California-Davis, Imaging Research Center | Sacramento | California | 95817 | — |
| Portland Identification and Early Referral Program | Portland | Maine | 04102 | — |
| Washtenaw County | Ann Arbor | Michigan | 48108 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131-0001 | — |
| Zucker Hillside Hosptial | Glen Oaks | New York | 11004 | — |
| Mid-Valley Behavioral Care Network | Salem | Oregon | 97301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00531518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00531518 live on ClinicalTrials.gov.